Amneal Pharmaceuticals Inc - Ordinary Shares - Class A
AMRX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.87B
Close$
$9.85
50.7% downside
Current Fair Value
50.7% downsideOvervalued by 50.7% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $6.87 Billion |
|---|---|
| Enterprise Value | $9.53 Billion |
| Earnings per Share | $0.23 |
| Beta | 1.22 |
| Outstanding Shares | 319,200,000 |
Return
| Return on Equity | 288.05% |
|---|---|
| Return on Assets | 2.52% |
| Return on Invested Capital | -7.54% |
Valuation & Multiples
| P/E Ratio | 43.24 |
|---|---|
| PEG | 27.5 |
| Price to Sales | 2.85 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3.98 |
| Enterprise Value to EBIT | -43.68 |
| Enterprise Value to Net Income | 100 |
| Total Debt to Enterprise | 0.29 |
| Debt to Equity | 84.54 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 3, 2026
EPS Estimate
$0.24
Consensus analyst estimateRevenue Estimate
$817.77 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 26, 2027
EPS Estimate
$0.24
Consensus analyst estimateRevenue Estimate
$834.52 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.06%▼ 48.24% |
|---|---|
| Total Invested | $131.50M▼ 95.40% |
| Investors Holding | 94▼ 221.00% |